Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.08 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.49.
Market Cap
9.08T
Revenue
4.67T
Profits
191.22B
PE Ratio
47.49
Profit Margin
4.10%
Dividend Yield
0.39%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.84% | 770,497 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 612.69B | -0.70% | 3,447,821 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 465.48B | 0.22% | 1,150,786 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 345.03B | -3.08% | 4,033,850 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 332.95B | -0.26% | 1,568,034 | 450.53B |
| 6 | NVS | Novartis AG | 266.66B | -0.51% | 551,328 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 246.69B | 1.89% | 573,508 | 46.34B |
| 8 | AZN | AstraZeneca PLC | 241.24B | -0.60% | 884,967 | 61.37B |
| 9 | AMGN | Amgen Inc. | 217.32B | -0.26% | 763,822 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 178.94B | -0.30% | 1,281,509 | 30.46B |
| 11 | ABT | Abbott Laboratories | 173.57B | 2.88% | 3,183,046 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 163.75B | -0.52% | 5,746,975 | 50.34B |
| 13 | PFE | Pfizer Inc. | 156.09B | -1.49% | 12,534,814 | 63.70B |
| 14 | DHR | Danaher Corporation | 153.41B | 1.95% | 652,063 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 142.99B | 3.26% | 559,817 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.79B | -0.11% | 228,757 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.59B | -3.46% | 8,296,183 | 49.19B |
| 18 | MDT | Medtronic plc | 112.27B | 1.61% | 12,708,284 | 37.54B |
| 19 | CVS | CVS Health Corporation | 110.84B | 0.23% | 2,963,702 | 412.65B |
| 20 | SYK | Stryker Corporation | 108.66B | 2.85% | 1,096,631 | 25.84B |
| 21 | MCK | McKesson Corporation | 105.92B | 0.68% | 108,304 | 410.98B |
| 22 | SNY | Sanofi | 95.48B | -1.42% | 1,506,301 | 55.89B |
| 23 | HCA | HCA Healthcare, Inc. | 94.36B | 2.15% | 296,076 | 78.01B |
| 24 | GSK | GSK plc | 94.34B | -1.17% | 1,754,190 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 85.03B | 1.46% | 177,567 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 78.69B | 3.73% | 8,364,695 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 72.44B | -1.33% | 192,688 | 15.53B |
| 28 | CI | The Cigna Group | 71.67B | 0.26% | 448,312 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 61.87B | 0.21% | 4,481,353 | 21.00B |
| 30 | NTRA | Natera, Inc. | 60.54B | 2.35% | 751,284 | 2.71B |
| 31 | COR | Cencora, Inc. | 59.82B | 1.43% | 221,161 | 332.77B |
| 32 | ARGX | argenx SE | 57.39B | -0.46% | 153,154 | 5.32B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 57.09B | 0.06% | 869,137 | 28.42B |
| 34 | CAH | Cardinal Health, Inc. | 53.77B | 1.71% | 432,437 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 50.15B | 2.18% | 793,942 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.78B | 1.28% | 411,852 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 48.01B | 1.50% | 402,641 | 7.37B |
| 38 | HUM | Humana Inc. | 47.39B | 1.62% | 340,001 | 145.68B |
| 39 | MDLN | Medline Inc. | 46.86B | 0.08% | 3,047,055 | 29.94B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 46.48B | 0.91% | 1,097,890 | 17.32B |
| 41 | VEEV | Veeva Systems Inc. | 44.68B | 0.95% | 379,049 | 3.46B |
| 42 | RVMD | Revolution Medicines, Inc. | 43.85B | -1.00% | 483,860 | - |
| 43 | IQV | IQVIA Holdings Inc. | 43.35B | 1.99% | 418,435 | 16.98B |
| 44 | ILMN | Illumina, Inc. | 42.77B | 3.75% | 1,243,014 | 4.49B |
| 45 | WAT | Waters Corporation | 42.71B | 2.23% | 462,577 | 4.64B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 41.30B | 1.12% | 110,302 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 40.90B | 0.45% | 83,115 | 6.13B |
| 48 | HLN | Haleon plc | 38.26B | 0.17% | 7,238,490 | 14.80B |
| 49 | DXCM | DexCom, Inc. | 32.69B | 1.50% | 701,982 | 4.97B |
| 50 | RPRX | Royalty Pharma plc | 32.45B | -1.26% | 827,027 | 2.54B |
| 51 | BIIB | Biogen Inc. | 32.29B | -0.62% | 257,622 | 10.03B |
| 52 | CNC | Centene Corporation | 31.44B | 1.03% | 1,283,376 | 180.30B |
| 53 | RMD | ResMed Inc. | 31.36B | 1.88% | 241,786 | 5.65B |
| 54 | ALC | Alcon Inc. | 30.80B | 0.31% | 340,811 | 10.86B |
| 55 | MTD | Mettler-Toledo International Inc. | 30.37B | 2.00% | 33,356 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 29.45B | 1.42% | 1,012,181 | 21.27B |
| 57 | ZTS | Zoetis Inc. | 29.24B | 1.55% | 1,140,335 | 9.53B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.05B | -1.20% | 457,137 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.33B | 2.49% | 271,838 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.05B | 0.95% | 1,516,821 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 25.46B | -1.12% | 273,466 | 11.56B |
| 62 | LH | Labcorp Holdings Inc. | 24.92B | -0.41% | 153,846 | 14.35B |
| 63 | GH | Guardant Health, Inc. | 24.63B | 3.22% | 479,858 | 1.18B |
| 64 | BNTX | BioNTech SE | 24.41B | 0.29% | 311,069 | 3.03B |
| 65 | PHG | Koninklijke Philips N.V. | 23.40B | -0.40% | 382,809 | 20.18B |
| 66 | UTHR | United Therapeutics Corporation | 23.35B | 0.48% | 280,489 | 3.15B |
| 67 | INCY | Incyte Corporation | 23.05B | -1.38% | 521,174 | 5.82B |
| 68 | INSM | Insmed Incorporated | 22.84B | -5.87% | 2,610,507 | 1.14B |
| 69 | THC | Tenet Healthcare Corporation | 21.21B | 1.84% | 119,150 | 21.81B |
| 70 | STE | STERIS plc | 20.48B | 0.71% | 206,008 | 6.04B |
| 71 | VTRS | Viatris Inc. | 20.32B | 0.51% | 2,149,171 | 14.74B |
| 72 | GMAB | Genmab A/S | 20.32B | 3.35% | 3,627,051 | 4.13B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.35B | 3.04% | 684,780 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 17.17B | 1.56% | 403,618 | 2.91B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.16B | 2.58% | 79,664 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.39B | 0.59% | 165,669 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.06B | 0.66% | 211,551 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.96B | 0.01% | 249,289 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.77B | 1.51% | 424,188 | 3.37B |
| 80 | TEM | Tempus AI, Inc. | 14.77B | 6.84% | 3,306,556 | 1.43B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.62B | 5.56% | 580,640 | 4.00B |
| 82 | EXEL | Exelixis, Inc. | 14.55B | 0.57% | 524,619 | 2.44B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.84B | 3.55% | 2,269,247 | - |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.03B | -0.91% | 675,773 | 713.07M |
| 85 | CORT | Corcept Therapeutics Incorporated | 12.96B | 3.16% | 207,851 | 830.81M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.85B | 2.36% | 775,855 | 14.37B |
| 87 | ICLR | ICON Public Limited Company | 12.75B | 2.01% | 284,891 | 8.29B |
| 88 | TWST | Twist Bioscience Corporation | 12.68B | 7.21% | 1,377,010 | 431.80M |
| 89 | PEN | Penumbra, Inc. | 12.53B | 0.14% | 103,875 | 1.50B |
| 90 | BAX | Baxter International Inc. | 12.47B | 2.70% | 4,233,269 | 11.47B |
| 91 | TXG | 10x Genomics, Inc. | 12.35B | 1.38% | 831,861 | 616.91M |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.34B | -1.06% | 358,332 | 1.66B |
| 93 | EHC | Encompass Health Corporation | 12.00B | 1.51% | 196,169 | 6.21B |
| 94 | FMS | Fresenius Medical Care AG | 11.80B | 1.21% | 236,662 | 22.19B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.39B | -1.28% | 63,092 | 1.28B |
| 96 | DVA | DaVita Inc. | 11.39B | -0.09% | 97,211 | 14.01B |
| 97 | TECH | Bio-Techne Corporation | 11.36B | 0.08% | 792,007 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.31B | 2.26% | 1,071,681 | 5.02B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.20B | 1.19% | 714,970 | 3.41B |
| 100 | PCVX | Vaxcyte, Inc. | 11.15B | 32.68% | 9,333,705 | - |
| 101 | SNN | Smith & Nephew plc | 11.01B | 1.55% | 1,067,194 | 6.30B |
| 102 | IBRX | ImmunityBio, Inc. | 10.90B | -0.05% | 10,113,350 | 165.79M |
| 103 | COO | The Cooper Companies, Inc. | 10.69B | -1.20% | 854,164 | 4.24B |
| 104 | AVTR | Avantor, Inc. | 10.53B | 1.47% | 2,133,450 | 6.56B |
| 105 | RDY | Dr. Reddy's Laboratories Limited | 10.47B | 0.33% | 742,938 | 3.50B |
| 106 | UHS | Universal Health Services, Inc. | 10.45B | 0.91% | 104,913 | 18.11B |
| 107 | RGEN | Repligen Corporation | 10.41B | 1.47% | 195,925 | 785.10M |
| 108 | GMED | Globus Medical, Inc. | 10.21B | 0.63% | 450,931 | 3.14B |
| 109 | ALGN | Align Technology, Inc. | 10.07B | -1.42% | 553,136 | 4.14B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.04B | 1.71% | 74,499 | 2.59B |
| 111 | ENSG | The Ensign Group, Inc. | 10.01B | 0.83% | 66,938 | 5.49B |
| 112 | MOH | Molina Healthcare, Inc. | 9.97B | 1.02% | 169,670 | 42.47B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.84B | 3.13% | 89,613 | 440.48M |
| 114 | OSCR | Oscar Health, Inc. | 9.81B | 2.88% | 1,353,566 | 15.32B |
| 115 | BRKR | Bruker Corporation | 9.71B | 0.81% | 439,402 | 3.50B |
| 116 | GKOS | Glaukos Corporation | 9.66B | 0.08% | 131,845 | 612.84M |
| 117 | QGEN | Qiagen N.V. | 9.37B | 1.27% | 1,265,434 | 2.10B |
| 118 | HSIC | Henry Schein, Inc. | 9.35B | -1.15% | 659,777 | 13.60B |
| 119 | PODD | Insulet Corporation | 9.34B | 2.31% | 328,502 | 3.05B |
| 120 | AXSM | Axsome Therapeutics, Inc. | 9.31B | -0.88% | 279,938 | 776.57M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.10B | 0.37% | 209,471 | 281.99M |
| 122 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.95B | -1.28% | 430,560 | 669.50M |
| 123 | CYTK | Cytokinetics, Incorporated | 8.87B | -2.77% | 1,123,527 | 67.67M |
| 124 | KYMR | Kymera Therapeutics, Inc. | 8.78B | -1.68% | 200,143 | 105.00M |
| 125 | CAI | Caris Life Sciences, Inc. | 8.42B | 5.30% | 1,227,866 | 989.61M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 7.99B | -2.71% | 153,492 | - |
| 127 | HNGE | Hinge Health, Inc. | 7.92B | 0.48% | 541,070 | 720.06M |
| 128 | ABVX | ABIVAX Société Anonyme | 7.91B | -1.79% | 354,100 | 5.33M |
| 129 | PRAX | Praxis Precision Medicines, Inc. | 7.86B | -4.70% | 176,519 | 7.46M |
| 130 | TGTX | TG Therapeutics, Inc. | 7.74B | 0.50% | 376,822 | 799.54M |
| 131 | ATR | AptarGroup, Inc. | 7.67B | 0.57% | 44,766 | 3.93B |
| 132 | HQY | HealthEquity, Inc. | 7.48B | 0.47% | 190,212 | 1.36B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.24B | 0.11% | 834,920 | 874.09M |
| 134 | ALKS | Alkermes plc | 7.20B | 2.73% | 876,634 | 1.67B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.10B | 0.37% | 685,616 | 3.12B |
| 136 | IMVT | Immunovant, Inc. | 6.87B | -1.10% | 207,491 | - |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.86B | 1.34% | 3,242,485 | 2.58B |
| 138 | PACS | PACS Group, Inc. | 6.74B | -0.64% | 111,741 | 5.55B |
| 139 | GRAL | GRAIL, Inc. | 6.67B | 4.23% | 470,864 | 165.26M |
| 140 | CHE | Chemed Corporation | 6.62B | 0.15% | 35,977 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.25% | 201,547 | 1.56B |
| 142 | GRFS | Grifols, S.A. | 6.44B | 0.82% | 176,812 | 8.48B |
| 143 | IOVA | Iovance Biotherapeutics, Inc. | 6.43B | -0.18% | 5,550,639 | 324.97M |
| 144 | BLTE | Belite Bio, Inc | 6.38B | -0.66% | 78,600 | - |
| 145 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.26B | -2.08% | 263,496 | 239.92M |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.13B | 1.51% | 41,451 | 290.54M |
| 147 | BLCO | Bausch + Lomb Corporation | 6.10B | -0.12% | 187,820 | 5.32B |
| 148 | CGON | CG Oncology, Inc. | 5.97B | -0.01% | 162,356 | 6.23M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.92B | 0.15% | 151,523 | 840.85M |
| 150 | KOD | Kodiak Sciences Inc. | 5.88B | -0.72% | 1,877,433 | - |
| 151 | MMED | MiniMed Group, Inc. | 5.60B | 1.12% | 2,798,248 | 3.22B |
| 152 | RDNT | RadNet, Inc. | 5.55B | 0.77% | 95,469 | 2.27B |
| 153 | ORKA | Oruka Therapeutics, Inc. | 5.52B | -1.41% | 149,947 | - |
| 154 | STVN | Stevanato Group S.p.A. | 5.50B | -0.30% | 54,268 | 1.40B |
| 155 | SRRK | Scholar Rock Holding Corporation | 5.45B | -4.42% | 723,484 | - |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.38B | 0.33% | 319,566 | 591.33M |
| 157 | TFX | Teleflex Incorporated | 5.38B | 2.32% | 118,441 | 2.25B |
| 158 | CRSP | CRISPR Therapeutics AG | 5.38B | 0.32% | 400,155 | 13.39M |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.36B | 1.29% | 212,532 | 1.01B |
| 160 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | -0.92% | 242,389 | 618.07M |
| 161 | COGT | Cogent Biosciences, Inc. | 5.32B | -1.14% | 590,651 | - |
| 162 | SHC | Sotera Health Company | 5.28B | 1.62% | 405,134 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.21B | 2.21% | 145,472 | 1.58B |
| 164 | BLLN | BillionToOne, Inc. | 5.14B | 2.93% | 155,546 | 397.41M |
| 165 | DOCS | Doximity, Inc. | 5.04B | 1.15% | 749,210 | 655.57M |
| 166 | WAY | Waystar Holding Corp. | 4.95B | 4.15% | 778,156 | 1.21B |
| 167 | ERAS | Erasca, Inc. | 4.95B | -3.93% | 1,122,202 | - |
| 168 | MANE | Veradermics, Incorporated | 4.91B | 0.69% | 142,401 | - |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -0.82% | 184,316 | 1.90M |
| 170 | DFTX | Definium Therapeutics, Inc. | 4.88B | -2.97% | 963,308 | - |
| 171 | HAE | Haemonetics Corporation | 4.79B | 0.61% | 103,880 | 1.35B |
| 172 | ADPT | Adaptive Biotechnologies Corporation | 4.66B | 3.10% | 427,364 | 308.08M |
| 173 | CON | Concentra Group Holdings Parent, Inc. | 4.62B | 1.60% | 245,773 | 2.29B |
| 174 | LFST | LifeStance Health Group, Inc. | 4.61B | 2.07% | 593,217 | 1.58B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.49B | -0.22% | 581,488 | - |
| 176 | HTFL | HeartFlow, Inc. | 4.43B | 3.39% | 339,056 | 212.07M |
| 177 | ABCL | AbCellera Biologics Inc. | 4.40B | -1.24% | 1,941,759 | 66.17M |
| 178 | ITGR | Integer Holdings Corporation | 4.30B | 0.12% | 147,783 | 1.84B |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.24B | 0.56% | 394,451 | 1.33B |
| 180 | LIVN | LivaNova PLC | 4.22B | 2.06% | 100,608 | 1.47B |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.12B | -0.74% | 615,116 | 10.35M |
| 182 | ICUI | ICU Medical, Inc. | 4.04B | 1.39% | 38,001 | 2.16B |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.77B | -3.70% | 778,643 | 53.81M |
| 184 | VCYT | Veracyte, Inc. | 3.76B | 2.12% | 193,847 | 561.90M |
| 185 | NVST | Envista Holdings Corporation | 3.76B | -0.21% | 826,328 | 2.86B |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.67B | 2.84% | 92,445 | 890.79M |
| 187 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | 0.64% | 191,497 | 234.13M |
| 188 | IRTC | iRhythm Holdings, Inc. | 3.62B | -0.42% | 136,557 | 825.34M |
| 189 | CDNA | CareDx, Inc. | 3.61B | 3.89% | 501,944 | 458.09M |
| 190 | NHC | National HealthCare Corporation | 3.60B | 1.08% | 28,029 | 1.56B |
| 191 | OGN | Organon & Co. | 3.60B | - | 525,408 | 6.13B |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.60B | -2.22% | 586,278 | 7.50M |
| 193 | PBLS | Parabilis Medicines, Inc. | 3.60B | -3.86% | 196,666 | 148.00K |
| 194 | RGC | Regencell Bioscience Holdings Limited | 3.59B | 6.16% | 124,299 | - |
| 195 | LEGN | Legend Biotech Corporation | 3.59B | -0.32% | 705,554 | 1.27B |
| 196 | PLSE | Pulse Biosciences, Inc. | 3.51B | 2.80% | 85,403 | 1.19M |
| 197 | CELC | Celcuity Inc. | 3.49B | -1.17% | 537,821 | - |
| 198 | OPCH | Option Care Health, Inc. | 3.47B | 2.41% | 269,042 | 5.69B |
| 199 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.47B | -0.50% | 309,779 | -665.00K |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.44B | -1.47% | 3,201,206 | - |
| 201 | ACAD | Acadia Pharmaceuticals Inc. | 3.39B | -1.40% | 547,918 | 1.14B |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.35B | -2.60% | 203,178 | - |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | 2.18% | 101,367 | 606.33M |
| 204 | WRBY | Warby Parker Inc. | 3.19B | -4.48% | 731,764 | 911.61M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.16B | -1.00% | 455,758 | 3.60M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | -0.36% | 510,512 | 463.98M |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.13B | 0.74% | 436,872 | 117.00M |
| 208 | TMDX | TransMedics Group, Inc. | 2.88B | 4.02% | 344,336 | 668.47M |
| 209 | DYN | Dyne Therapeutics, Inc. | 2.87B | 0.99% | 1,793,102 | - |
| 210 | PGEN | Precigen, Inc. | 2.84B | -7.03% | 3,867,302 | 85.72M |
| 211 | ATRC | AtriCure, Inc. | 2.83B | 0.80% | 313,005 | 569.62M |
| 212 | ZLAB | Zai Lab Limited | 2.82B | 3.29% | 305,174 | 449.61M |
| 213 | MBX | MBX Biosciences, Inc. | 2.79B | -1.02% | 80,528 | - |
| 214 | NEOG | Neogen Corporation | 2.74B | 3.54% | 1,112,463 | 870.40M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.72B | -0.87% | 769,866 | 2.60B |
| 216 | NAMS | NewAmsterdam Pharma Company N.V. | 2.71B | -2.33% | 478,003 | 7.12M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.69B | 0.02% | 37,940 | 1.46B |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.67B | 2.07% | 277,051 | 3.37B |
| 219 | PRVA | Privia Health Group, Inc. | 2.60B | 0.20% | 409,895 | 2.36B |
| 220 | BKD | Brookdale Senior Living Inc. | 2.55B | -1.57% | 1,153,541 | 2.93B |
| 221 | RXRX | Recursion Pharmaceuticals, Inc. | 2.54B | 15.05% | 34,140,030 | 54.86M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.53B | 1.86% | 336,724 | 158.00K |
| 223 | LQDA | Liquidia Corporation | 2.51B | -2.16% | 3,078,485 | 450.91M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.48B | 0.83% | 439,031 | 830.44M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.48B | 1.22% | 502,379 | 156.04M |
| 226 | HCM | HUTCHMED (China) Limited | 2.47B | - | 18,315 | 549.12M |
| 227 | IRON | Disc Medicine, Inc. | 2.44B | -1.62% | 141,426 | - |
| 228 | SDGR | Schrödinger, Inc. | 2.43B | 7.14% | 1,979,918 | 259.04M |
| 229 | NEO | NeoGenomics, Inc. | 2.43B | 2.22% | 365,975 | 766.30M |
| 230 | BFLY | Butterfly Network, Inc. | 2.42B | 1.68% | 1,930,759 | 112.14M |
| 231 | CLOV | Clover Health Investments, Corp. | 2.42B | 4.11% | 1,482,468 | 2.48B |
| 232 | IMNM | Immunome, Inc. | 2.41B | 1.58% | 279,795 | 4.02M |
| 233 | ALMR | Alamar Biosciences, Inc. | 2.41B | 0.90% | 48,651 | 100.42M |
| 234 | NRIX | Nurix Therapeutics, Inc. | 2.37B | -0.48% | 202,172 | 36.77M |
| 235 | UFPT | UFP Technologies, Inc. | 2.37B | 1.76% | 34,214 | 631.64M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.37B | 2.60% | 158,362 | 959.90M |
| 237 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | -1.53% | 2,402,535 | - |
| 238 | ADMA | ADMA Biologics, Inc. | 2.26B | 3.91% | 1,112,860 | 512.28M |
| 239 | WGS | GeneDx Holdings Corp. | 2.26B | 3.56% | 157,571 | 454.43M |
| 240 | ALVO | Alvotech | 2.21B | 13.49% | 2,072,141 | 494.61M |
| 241 | AXGN | Axogen, Inc. | 2.20B | 0.40% | 498,540 | 251.17M |
| 242 | BHC | Bausch Health Companies Inc. | 2.18B | 0.60% | 415,176 | 10.85B |
| 243 | PHVS | Pharvaris N.V. | 2.16B | -1.41% | 193,854 | - |
| 244 | VRDN | Viridian Therapeutics, Inc. | 2.16B | -1.80% | 745,068 | 71.13M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | 0.22% | 77,017 | 1.10B |
| 246 | VERA | Vera Therapeutics, Inc. | 2.13B | -2.89% | 563,196 | - |
| 247 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.13B | 3.73% | 741,667 | 208.78M |
| 248 | ADRX | ADARx Pharmaceuticals, Inc. | 2.10B | 2.85% | 447,529 | 6.13M |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -0.76% | 255,324 | 311.51M |
| 250 | MD | Pediatrix Medical Group, Inc. | 2.08B | 1.06% | 71,897 | 1.95B |
| 251 | ADUS | Addus HomeCare Corporation | 2.07B | 1.73% | 62,467 | 1.48B |
| 252 | VCEL | Vericel Corporation | 2.07B | 0.52% | 177,305 | 306.30M |
| 253 | MLYS | Mineralys Therapeutics, Inc. | 2.06B | -1.44% | 283,287 | - |
| 254 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.05B | -1.77% | 1,050,713 | 940.61M |
| 255 | TRLV | Trulieve Cannabis Corp. | 2.04B | -1.03% | 814,595 | 1.14B |
| 256 | INSP | Inspire Medical Systems, Inc. | 2.04B | 0.99% | 104,053 | 898.74M |
| 257 | URGN | UroGen Pharma Ltd. | 2.03B | 0.48% | 475,422 | 188.73M |
| 258 | FTRE | Fortrea Holdings Inc. | 2.01B | 5.72% | 468,577 | 2.68B |
| 259 | PRGO | Perrigo Company plc | 1.99B | 0.60% | 433,759 | 4.14B |
| 260 | ESTA | Establishment Labs Holdings Inc. | 1.98B | 3.97% | 94,754 | 245.82M |
| 261 | TRVI | Trevi Therapeutics, Inc. | 1.96B | -0.86% | 661,758 | - |
| 262 | BHVN | Biohaven Ltd. | 1.96B | 0.70% | 747,890 | - |
| 263 | GPCR | Structure Therapeutics Inc. | 1.95B | -0.94% | 640,860 | - |
| 264 | PGNY | Progyny, Inc. | 1.95B | 0.75% | 240,099 | 1.31B |
| 265 | XNCR | Xencor, Inc. | 1.91B | 3.66% | 299,455 | 104.97M |
| 266 | ABSI | Absci Corporation | 1.91B | 0.63% | 1,669,822 | 1.56M |
| 267 | VIR | Vir Biotechnology, Inc. | 1.90B | 0.45% | 573,796 | 303.23M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.89B | -0.88% | 51,981 | - |
| 269 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 1.21% | 261,252 | 1.13B |
| 270 | ASTH | Astrana Health, Inc. | 1.87B | 1.95% | 79,905 | 3.84B |
| 271 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 2.85% | 64,471 | 262.43M |
| 272 | AGIO | Agios Pharmaceuticals, Inc. | 1.86B | -2.22% | 148,662 | 98.34M |
| 273 | ZYME | Zymeworks Inc. | 1.86B | 3.98% | 221,954 | 37.13M |
| 274 | BLFS | BioLife Solutions, Inc. | 1.85B | 1.23% | 210,623 | 106.69M |
| 275 | SRPT | Sarepta Therapeutics, Inc. | 1.84B | -0.31% | 606,195 | 1.97B |
| 276 | ZBIO | Zenas BioPharma, Inc. | 1.84B | -0.41% | 149,697 | 1.00M |
| 277 | MESO | Mesoblast Limited | 1.83B | 0.64% | 89,659 | 120.25M |
| 278 | XERS | Xeris Biopharma Holdings, Inc. | 1.82B | 9.86% | 1,886,680 | 335.41M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.78B | -0.05% | 94,055 | 481.07M |
| 280 | FRNM | Freenome, Inc. | 1.78B | 1.78% | 272,780 | 35.41M |
| 281 | AZTA | Azenta, Inc. | 1.78B | 5.11% | 795,987 | 613.81M |
| 282 | GENB | Generate Biomedicines, Inc. | 1.78B | 1.53% | 462,683 | 26.48M |
| 283 | NVAX | Novavax, Inc. | 1.78B | 3.35% | 1,845,001 | 413.80M |
| 284 | NVCR | NovoCure Limited | 1.77B | 1.64% | 426,766 | 699.19M |
| 285 | SEPN | Septerna, Inc. | 1.77B | 0.45% | 118,715 | 98.88M |
| 286 | PSNL | Personalis, Inc. | 1.75B | 0.43% | 272,319 | 69.67M |
| 287 | NUVB | Nuvation Bio Inc. | 1.75B | -3.31% | 3,043,278 | 169.90M |
| 288 | SGRY | Surgery Partners, Inc. | 1.73B | 0.23% | 144,010 | 3.37B |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.73B | 0.73% | 2,313,403 | 59.51M |
| 290 | XRAY | DENTSPLY SIRONA Inc. | 1.72B | -0.40% | 1,726,104 | 3.64B |
| 291 | BRVE | Braveheart Bio, Inc. | 1.69B | -3.39% | 265,302 | - |
| 292 | ALHC | Alignment Healthcare, Inc. | 1.69B | 2.52% | 3,290,634 | 4.58B |
| 293 | KMTS | Kestra Medical Technologies, Ltd. | 1.66B | 1.90% | 60,761 | 106.73M |
| 294 | STOK | Stoke Therapeutics, Inc. | 1.63B | -1.68% | 159,915 | 27.59M |
| 295 | ETON | Eton Pharmaceuticals, Inc. | 1.62B | 2.44% | 129,796 | 105.60M |
| 296 | ATEC | Alphatec Holdings, Inc. | 1.61B | 3.94% | 702,106 | 815.05M |
| 297 | CMPS | COMPASS Pathways plc | 1.60B | -2.86% | 1,442,101 | - |
| 298 | QURE | uniQure N.V. | 1.60B | -1.79% | 1,641,742 | 18.67M |
| 299 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | 1.59% | 435,738 | 252.25M |
| 300 | OMCL | Omnicell, Inc. | 1.55B | 1.37% | 63,003 | 1.25B |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 0.34% | 59,111 | 978.38M |
| 302 | OCUL | Ocular Therapeutix, Inc. | 1.54B | 0.86% | 2,166,304 | 52.06M |
| 303 | RAPP | Rapport Therapeutics, Inc. | 1.54B | -0.51% | 43,114 | 20.00M |
| 304 | PAHC | Phibro Animal Health Corporation | 1.53B | 1.48% | 72,256 | 1.52B |
| 305 | GHRS | GH Research PLC | 1.53B | -2.77% | 65,219 | - |
| 306 | IMCR | Immunocore Holdings plc | 1.53B | -0.22% | 73,415 | 430.78M |
| 307 | ARDT | Ardent Health, Inc. | 1.51B | 3.58% | 59,751 | 6.41B |
| 308 | NUTX | Nutex Health Inc. | 1.51B | 1.56% | 64,579 | 846.72M |
| 309 | CERT | Certara, Inc. | 1.49B | 4.33% | 914,173 | 421.75M |
| 310 | INVA | Innoviva, Inc. | 1.48B | 0.05% | 211,684 | 440.00M |
| 311 | ANAB | AnaptysBio, Inc. | 1.46B | 0.76% | 119,191 | 106.09M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.46B | -0.51% | 123,235 | 20.00M |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.45B | 1.05% | 199,753 | 1.86B |
| 314 | TSHA | Taysha Gene Therapies, Inc. | 1.44B | -4.43% | 1,045,971 | 5.49M |
| 315 | NKTR | Nektar Therapeutics | 1.44B | -3.14% | 591,415 | 54.59M |
| 316 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -4.20% | 1,341,005 | 717.00M |
| 317 | COAG | Hemab Therapeutics Holdings, Inc. | 1.43B | -1.61% | 69,885 | - |
| 318 | CNMD | CONMED Corporation | 1.42B | 2.59% | 47,222 | 1.37B |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.42B | 1.32% | 197,259 | - |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.42B | -0.35% | 46,665 | 1.30M |
| 321 | AMN | AMN Healthcare Services, Inc. | 1.42B | 0.01% | 155,359 | 3.43B |
| 322 | AGL | agilon health, inc. | 1.41B | -0.14% | 48,660 | 5.92B |
| 323 | PNTG | The Pennant Group, Inc. | 1.41B | 2.77% | 60,473 | 1.10B |
| 324 | KARD | Kardigan, Inc. | 1.39B | 0.54% | 127,108 | - |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -0.78% | 203,729 | - |
| 326 | DRTS | Alpha Tau Medical Ltd. | 1.37B | 0.54% | 129,503 | - |
| 327 | KRSA | Korsana Biosciences, Inc. | 1.37B | -1.61% | 56,285 | - |
| 328 | OMER | Omeros Corporation | 1.35B | 0.30% | 190,993 | 38.42M |
| 329 | KLRA | Kailera Therapeutics, Inc. | 1.32B | -1.92% | 356,481 | - |
| 330 | AAPG | Ascentage Pharma Group International | 1.31B | -5.11% | 2,375 | 94.61M |
| 331 | NBTX | Nanobiotix S.A. | 1.31B | -2.87% | 142,339 | 13.15M |
| 332 | ORIC | ORIC Pharmaceuticals, Inc. | 1.28B | 1.52% | 517,796 | - |
| 333 | OMDA | Omada Health, Inc. | 1.26B | 1.13% | 142,390 | 309.76M |
| 334 | USPH | U.S. Physical Therapy, Inc. | 1.26B | 0.67% | 68,245 | 804.27M |
| 335 | DMRA | Damora Therapeutics, Inc. | 1.23B | -3.20% | 219,103 | - |
| 336 | INNV | InnovAge Holding Corp. | 1.23B | 0.22% | 123,763 | 989.71M |
| 337 | SVRA | Savara Inc. | 1.22B | -0.21% | 656,402 | - |
| 338 | REPL | Replimune Group, Inc. | 1.22B | -0.99% | 1,007,750 | - |
| 339 | MNKD | MannKind Corporation | 1.22B | -0.53% | 781,687 | 393.63M |
| 340 | CRON | Cronos Group Inc. | 1.19B | 1.40% | 669,041 | 179.09M |
| 341 | TRAX | First Tracks Biotherapeutics, Inc. | 1.18B | -0.42% | 215,222 | - |
| 342 | AVLN | Avalyn Pharma Inc. | 1.18B | -5.44% | 145,813 | - |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | 2.24% | 395,430 | 1.04B |
| 344 | OPK | OPKO Health, Inc. | 1.16B | - | 669,401 | 587.90M |
| 345 | GDRX | GoodRx Holdings, Inc. | 1.16B | 3.66% | 344,129 | 785.23M |
| 346 | HROW | Harrow, Inc. | 1.15B | 0.69% | 186,305 | 275.59M |
| 347 | BCAX | Bicara Therapeutics Inc. | 1.15B | -1.47% | 178,177 | - |
| 348 | LBRX | LB Pharmaceuticals Inc | 1.15B | -3.70% | 135,999 | - |
| 349 | BVS | Bioventus Inc. | 1.13B | 2.67% | 92,761 | 581.85M |
| 350 | AORT | Artivion, Inc. | 1.11B | 2.42% | 167,982 | 471.47M |
| 351 | VOR | Vor Biopharma Inc. | 1.11B | - | 169,290 | - |
| 352 | IRMD | IRADIMED CORPORATION | 1.11B | 1.25% | 30,560 | 86.34M |
| 353 | STAA | STAAR Surgical Company | 1.11B | -1.87% | 117,169 | 339.59M |
| 354 | CSTL | Castle Biosciences, Inc. | 1.10B | 0.98% | 32,522 | 357.28M |
| 355 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.09B | 0.57% | 94,182 | 730.02M |
| 356 | LTGO | Latigo Biotherapeutics, Inc. | 1.08B | 2.01% | 95,592 | - |
| 357 | ENOV | Enovis Corporation | 1.06B | 3.21% | 236,009 | 2.30B |
| 358 | IMTX | Immatics N.V. | 1.05B | 1.19% | 207,104 | 47.65M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.05B | 1.11% | 207,671 | 397.50M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 4.17% | 147,314 | 1.04B |
| 361 | IART | Integra LifeSciences Holdings Corporation | 1.03B | 4.26% | 544,507 | 1.65B |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.02B | 4.02% | 251,887 | 337.34M |
| 363 | TDOC | Teladoc Health, Inc. | 1.02B | 1.63% | 1,244,002 | 2.49B |
| 364 | AKTS | Aktis Oncology, Inc. | 1.01B | -2.05% | 81,606 | 10.06M |
| 365 | BBNX | Beta Bionics, Inc. | 1.01B | 0.79% | 174,133 | 119.01M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 0.77% | 261,655 | - |
| 367 | PCRX | Pacira BioSciences, Inc. | 1.00B | -0.18% | 144,563 | 746.16M |
| 368 | JANX | Janux Therapeutics, Inc. | 1.00B | -3.19% | 167,103 | 24.00M |
| 369 | DNA | Ginkgo Bioworks Holdings, Inc. | 991.25M | 19.19% | 3,916,258 | 132.42M |
| 370 | SPTX | Seaport Therapeutics, Inc. | 982.82M | -0.33% | 43,371 | - |
| 371 | ODTX | Odyssey Therapeutics, Inc. | 978.49M | -1.47% | 61,902 | 99.00K |
| 372 | MLTX | MoonLake Immunotherapeutics | 975.32M | 0.44% | 765,730 | - |
| 373 | HSTM | HealthStream, Inc. | 959.33M | 1.74% | 37,273 | 321.12M |
| 374 | ANRO | Alto Neuroscience, Inc. | 954.37M | -1.94% | 142,033 | - |
| 375 | ANL | Adlai Nortye Group Ltd. | 946.65M | -2.58% | 389,663 | 18.06M |
| 376 | AHG | Akso Health Group | 941.52M | -4.43% | 19,293 | 13.83M |
| 377 | CBLL | CeriBell, Inc. | 939.88M | 3.38% | 83,752 | 101.96M |
| 378 | KURA | Kura Oncology, Inc. | 939.42M | -0.85% | 441,791 | 77.23M |
| 379 | ABUS | Arbutus Biopharma Corporation | 918.01M | 4.27% | 1,173,593 | 181.72M |
| 380 | JBIO | Jade Biosciences, Inc. | 909.44M | 1.27% | 189,443 | - |
| 381 | APMD | Apnimed, Inc. | 900.27M | 0.53% | 177,362 | 115.12M |
| 382 | RIGL | Rigel Pharmaceuticals, Inc. | 896.82M | 1.82% | 94,517 | 276.79M |
| 383 | SLBT | SL Science Holding Limited | 895.32M | - | 51,465 | 3.27M |
| 384 | ALMS | Alumis Inc. | 895.04M | 0.95% | 566,799 | 7.40M |
| 385 | CRVS | Corvus Pharmaceuticals, Inc. | 892.52M | -2.66% | 242,114 | - |
| 386 | GLUE | Monte Rosa Therapeutics, Inc. | 879.15M | -1.86% | 620,866 | 28.73M |
| 387 | SIBN | SI-BONE, Inc. | 874.41M | 7.91% | 214,165 | 213.60M |
| 388 | SANA | Sana Biotechnology, Inc. | 871.14M | 0.69% | 1,361,879 | - |
| 389 | HELP | Helus Pharma Inc. | 850.42M | -0.51% | 707,920 | - |
| 390 | SGP | SpyGlass Pharma, Inc. | 849.41M | 1.91% | 50,822 | - |
| 391 | ARDX | Ardelyx, Inc. | 848.48M | 1.95% | 1,674,816 | 450.89M |
| 392 | IVA | Inventiva S.A. | 836.35M | -3.37% | 838,825 | 2.81M |
| 393 | PACB | Pacific Biosciences of California, Inc. | 833.03M | 5.51% | 10,090,898 | 159.27M |
| 394 | IMMX | Immix Biopharma, Inc. | 824.06M | 2.69% | 544,368 | - |
| 395 | QDEL | QuidelOrtho Corporation | 821.53M | 11.23% | 646,481 | 2.67B |
| 396 | OBX | Obsidian Therapeutics, Inc. | 812.93M | -3.16% | 34,329 | - |
| 397 | INMD | InMode Ltd. | 810.48M | 0.07% | 232,437 | 374.63M |
| 398 | ATTO | Attovia Therapeutics, Inc. | 805.06M | 2.71% | 86,830 | 1.80M |
| 399 | ANNX | Annexon, Inc. | 799.08M | 0.60% | 1,070,420 | - |
| 400 | CADL | Candel Therapeutics, Inc. | 788.14M | 1.18% | 385,999 | - |
| 401 | LXRX | Lexicon Pharmaceuticals, Inc. | 783.12M | -3.30% | 544,529 | 41.47M |
| 402 | VREX | Varex Imaging Corporation | 779.32M | 0.16% | 51,130 | 865.00M |
| 403 | AVTX | Avalo Therapeutics, Inc. | 777.63M | -3.27% | 210,060 | 59.00K |
| 404 | CTKB | Cytek Biosciences, Inc. | 772.10M | 1.19% | 646,068 | 206.71M |
| 405 | GYRE | Gyre Therapeutics, Inc. | 770.34M | 2.18% | 23,121 | 109.82M |
| 406 | DSGN | Design Therapeutics, Inc. | 769.13M | -0.41% | 332,404 | - |
| 407 | GERN | Geron Corporation | 767.76M | -0.42% | 2,685,636 | 204.56M |
| 408 | GMRS | GMR Solutions Inc. | 764.00M | -0.61% | 82,985 | 5.88B |
| 409 | SLDB | Solid Biosciences Inc. | 762.37M | 3.80% | 399,575 | - |
| 410 | AHCO | AdaptHealth Corp. | 753.76M | 0.89% | 530,060 | 3.36B |
| 411 | WVE | Wave Life Sciences, Inc. | 750.75M | 0.79% | 1,452,673 | 65.37M |
| 412 | AVR | Anteris Technologies Global Corp. | 732.18M | -2.59% | 902,978 | 2.24M |
| 413 | ACHV | Achieve Life Sciences, Inc. | 722.38M | -3.04% | 555,990 | - |
| 414 | COLL | Collegium Pharmaceutical, Inc. | 715.57M | -0.18% | 252,010 | 808.21M |
| 415 | VSTM | Verastem, Inc. | 712.73M | 2.21% | 494,501 | 87.53M |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 712.65M | -5.63% | 1,345,001 | 92.01M |
| 417 | FTH | Faeth Therapeutics, Inc. | 710.09M | -3.07% | 183,120 | - |
| 418 | OABI | OmniAb, Inc. | 700.78M | -1.03% | 328,453 | 38.46M |
| 419 | OLMA | Olema Pharmaceuticals, Inc. | 696.92M | -3.16% | 236,185 | - |
| 420 | PHAR | Pharming Group N.V. | 693.58M | 0.77% | 4,760 | 366.48M |
| 421 | SOPH | SOPHiA GENETICS SA | 690.39M | 0.50% | 491,852 | 86.17M |
| 422 | MDXG | MiMedx Group, Inc. | 677.06M | 1.20% | 238,810 | 355.17M |
| 423 | NVCT | Nuvectis Pharma, Inc. | 667.76M | -6.50% | 51,902 | - |
| 424 | AURA | Aura Biosciences, Inc. | 653.34M | 3.45% | 161,547 | - |
| 425 | STLN | Starling Oncology, Inc. | 645.64M | -0.24% | 351,529 | 587.24M |
| 426 | PHR | Phreesia, Inc. | 644.30M | 3.08% | 141,473 | 507.79M |
| 427 | ANGO | AngioDynamics, Inc. | 642.72M | 2.91% | 136,558 | 320.17M |
| 428 | STTK | Shattuck Labs, Inc. | 642.32M | -4.90% | 302,681 | 1.00M |
| 429 | CLYM | Climb Bio, Inc. | 637.54M | 1.46% | 477,878 | - |
| 430 | DBVT | DBV Technologies S.A. | 634.13M | 0.74% | 178,026 | 5.04M |
| 431 | BLSM | BlossomHill Therapeutics, Inc. | 623.62M | -0.36% | 46,999 | - |
| 432 | SLN | Silence Therapeutics plc | 620.16M | -3.20% | 357,436 | 615.00K |
| 433 | ACRS | Aclaris Therapeutics, Inc. | 618.24M | -4.33% | 3,997,199 | 8.22M |
| 434 | SGMT | Sagimet Biosciences Inc. | 616.91M | -4.81% | 673,024 | - |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 611.65M | 3.10% | 557,592 | 136.07M |
| 436 | ETRA | Electra Therapeutics, Inc. | 606.96M | -6.75% | 149,371 | - |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 599.82M | -0.27% | 613,630 | 389.32M |
| 438 | CBIO | Crescent Biopharma, Inc. | 598.79M | -2.30% | 46,411 | 11.88M |
| 439 | FLGT | Fulgent Genetics, Inc. | 594.88M | 0.65% | 52,222 | 323.93M |
| 440 | WEAV | Weave Communications, Inc. | 589.19M | -0.07% | 409,896 | 257.79M |
| 441 | KIDS | OrthoPediatrics Corp. | 587.08M | 1.47% | 58,849 | 252.72M |
| 442 | EVO | Evotec SE | 584.16M | 1.39% | 87,164 | 819.47M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 569.82M | -0.22% | 393,687 | 54.09M |
| 444 | CRMD | CorMedix Inc. | 564.32M | 0.70% | 605,392 | 462.25M |
| 445 | CTMX | CytomX Therapeutics, Inc. | 551.29M | -1.17% | 669,085 | 18.30M |
| 446 | PRME | Prime Medicine, Inc. | 546.17M | 3.02% | 1,140,785 | 4.07M |
| 447 | SSII | SS Innovations International, Inc. | 545.35M | 1.93% | 24,237 | 52.40M |
| 448 | DCTH | Delcath Systems, Inc. | 545.12M | 3.83% | 89,150 | 95.42M |
| 449 | OCS | Oculis Holding AG | 543.86M | 0.92% | 70,836 | 1.45M |
| 450 | SENS | Senseonics Holdings, Inc. | 541.96M | 3.74% | 257,074 | 48.55M |
| 451 | PHAT | Phathom Pharmaceuticals, Inc. | 540.92M | -1.59% | 410,619 | 239.66M |
| 452 | VALN | Valneva SE | 540.23M | 1.48% | 8,313 | 163.30M |
| 453 | MNPR | Monopar Therapeutics Inc. | 532.01M | 1.65% | 73,675 | - |
| 454 | YDES | YD Bio Limited | 525.57M | -8.51% | 154,499 | 1.24M |
| 455 | RGNX | REGENXBIO Inc. | 522.82M | 6.59% | 1,126,555 | 174.48M |
| 456 | MASS | 908 Devices Inc. | 522.04M | -0.47% | 142,585 | 60.84M |
| 457 | ALT | Altimmune, Inc. | 521.07M | -2.05% | 1,498,291 | 31.00K |
| 458 | NGNE | Neurogene Inc. | 518.90M | 1.09% | 66,620 | 925.00K |
| 459 | ALLO | Allogene Therapeutics, Inc. | 518.24M | - | 2,067,525 | 4.64M |
| 460 | MPLT | MapLight Therapeutics, Inc. | 516.85M | -5.30% | 88,610 | - |
| 461 | TLRY | Tilray Brands, Inc. | 509.62M | 3.05% | 2,491,293 | 915.45M |
| 462 | TCMD | Tactile Systems Technology, Inc. | 506.05M | 1.09% | 44,656 | 350.31M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 464 | PBYI | Puma Biotechnology, Inc. | 499.17M | 1.68% | 110,243 | 231.24M |
| 465 | PROK | ProKidney Corp. | 497.32M | -4.36% | 344,575 | 818.00K |
| 466 | GLAS | Glass House Brands Inc. | 495.72M | -4.19% | 484,621 | 176.98M |
| 467 | DRUG | Bright Minds Biosciences Inc. | 488.45M | -0.45% | 20,930 | - |
| 468 | BWAY | BrainsWay Ltd. | 488.12M | -2.56% | 146,992 | 60.70M |
| 469 | ARVN | Arvinas, Inc. | 487.78M | 0.67% | 149,717 | 316.70M |
| 470 | EOLS | Evolus, Inc. | 486.13M | 3.08% | 275,068 | 316.49M |
| 471 | SGHT | Sight Sciences, Inc. | 482.57M | 2.70% | 162,342 | 83.38M |
| 472 | TKNO | Alpha Teknova, Inc. | 480.24M | -0.50% | 127,248 | 43.70M |
| 473 | CAPR | Capricor Therapeutics, Inc. | 479.94M | -7.77% | 2,377,416 | 11.13M |
| 474 | AUTL | Autolus Therapeutics plc | 479.09M | 1.12% | 787,646 | 117.39M |
| 475 | EPRX | Eupraxia Pharmaceuticals Inc. | 477.13M | 6.63% | 543,996 | - |
| 476 | CTNM | Contineum Therapeutics, Inc. | 474.97M | -3.77% | 130,788 | - |
| 477 | ENTX | Entera Bio Ltd. | 464.02M | -6.29% | 333,422 | 42.00K |
| 478 | CERS | Cerus Corporation | 463.51M | 0.88% | 422,090 | 221.55M |
| 479 | NRC | NRC Health | 461.86M | 2.60% | 29,676 | 140.00M |
| 480 | ASMB | Assembly Biosciences, Inc. | 459.23M | 0.07% | 67,343 | 74.85M |
| 481 | KMDA | Kamada Ltd. | 457.69M | -3.85% | 80,079 | 191.85M |
| 482 | OVID | Ovid Therapeutics Inc. | 455.04M | -2.10% | 424,947 | 1.58M |
| 483 | DMAC | DiaMedica Therapeutics Inc. | 454.59M | 2.43% | 61,333 | - |
| 484 | NPCE | NeuroPace, Inc. | 444.16M | 1.89% | 32,079 | 106.99M |
| 485 | RZLT | Rezolute, Inc. | 435.32M | 3.49% | 1,306,621 | - |
| 486 | MYGN | Myriad Genetics, Inc. | 435.21M | 0.22% | 433,359 | 806.60M |
| 487 | TECX | Tectonic Therapeutic, Inc. | 429.11M | -2.62% | 81,631 | - |
| 488 | SRTA | Strata Critical Medical, Inc. | 427.29M | 2.11% | 433,385 | 255.98M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 427.13M | 5.53% | 640,409 | 116.93M |
| 490 | PRTA | Prothena Corporation plc | 412.75M | -3.83% | 244,856 | 54.53M |
| 491 | EDIT | Editas Medicine, Inc. | 410.83M | 2.10% | 1,185,698 | 47.01M |
| 492 | AGMB | AgomAb Therapeutics NV | 408.02M | -3.21% | 58,670 | - |
| 493 | AVIR | Atea Pharmaceuticals, Inc. | 406.64M | -1.17% | 33,072 | - |
| 494 | SI | Shoulder Innovations, Inc. | 405.97M | 2.58% | 19,170 | 60.06M |
| 495 | RCEL | AVITA Medical, Inc. | 403.60M | 2.59% | 160,691 | 75.63M |
| 496 | CARL | Carlsmed, Inc. | 402.72M | 3.36% | 54,297 | 63.30M |
| 497 | EVH | Evolent Health, Inc. | 400.23M | 2.31% | 325,359 | 2.10B |
| 498 | KYTX | Kyverna Therapeutics, Inc. | 393.32M | 2.25% | 431,569 | - |
| 499 | CTEV | Claritev Corporation | 393.27M | -2.17% | 60,846 | 994.67M |
| 500 | EIKN | Eikon Therapeutics, Inc. | 391.61M | -1.36% | 177,250 | - |